American Heart Association

AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.

In the SOLOIST-WHF trial, risk for HF readmission and CV death were reduced by more than 50% at 30- and 90-days after hospital discharge.

AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.

AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.

AHA 2022. A perception of discrimination was associated with worse mental health and disease-related health status 1 year post-MI among adults aged ≤55 years.

AHA 2021: New research showed MK-0616, an investigative oral PCSK9 inhibitor, was associated with a near 65% decrease in LDL-C.

Smoking was associated with earlier onset of cardiovascular disease, by 5.1 years for men and 3.8 years for women, the new study found.

AHA 2021. Heart failure patients, across ejection fraction and diabetes status, reported improved QOL as early as 3 months in CHIEF-HF trial.

AHA 2021: Study suggests remote hypertension and hyperlipidemia management programs may expand telehealth delivery, increase access to care, and reduce health inequities.

AHA 2021: Marcus, lead author of CRAVE, says it found little effect of caffeine on atrial arrhythmias, a significant effect on PVCs, a negative effect on sleep, and a boosting effect on physical activity.

AHA 2021: Novel software algorithm used in Fitbit wearable devices accurately detected undiagnosed atrial fibrillation about 98% of the time, showed results of the Fitbit Heart Study.

AHA 2021. Coffee increased PVCs by 54% in regular coffee drinkers and decreased sleep by more than 30 minutes; it also significantly increased daily step count and slightly improved SVT.

AHA Scientific Sessions 2021: New research provides a note of caution for the use of digital heart failure coaching apps in severely ill and elderly patients with unstable heart failure.

AHA Scientific Sessions 2021: Employment status and higher caregiver burden were linked to increased engagement with a videoconferencing-based intervention to reduce the risk of CVD.

EHR-integrated remote BP monitoring was evaluated in a primary care Medicare population to assess uptake and initial effects on hypertension management.

AHA Scientific Sessions 2021. Statin-associated muscle symptoms complicate treatment initiation and adherence; a new mHealth tool shows promise in reducing treatment cessation.

AHA Scientific Sessions 2021: Blood pressure reductions to clinical targets were achieved by patients with sustained hypertension through a remote health care delivery program during the COVID-19 pandemic.

AHA Scientific Sessions 2021: New research found living in socially vulnerable neighborhoods increased the risk of myocardial infarction, stroke, or death among hospitalized COVID-19 patients.

AHA 2021: E-cigarette users were found to have a 15% higher risk of a cerebrovascular accident at a younger age than those who smoked combustible tobacco cigarettes.

AHA Scientific Sessions 2021: National study of over 2.9 million young Black adults showed increased rates of CVD risk factors and worsened hospital outcomes between 2007 and 2017.